位置:首页 > 蛋白库 > TLR4_BOSTR
TLR4_BOSTR
ID   TLR4_BOSTR              Reviewed;         841 AA.
AC   Q2V898;
DT   17-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   10-JAN-2006, sequence version 1.
DT   25-MAY-2022, entry version 82.
DE   RecName: Full=Toll-like receptor 4;
DE   AltName: CD_antigen=CD284;
DE   Flags: Precursor;
GN   Name=TLR4;
OS   Boselaphus tragocamelus (Nilgai).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae;
OC   Bovinae; Boselaphus.
OX   NCBI_TaxID=9917;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Das D.K., Saini M., Swarup D., Yadav M.P., Sharma B., Gupta P.K.;
RT   "Full-length cDNA cloning of toll-like receptor 4 in Boselaphus
RT   tragocamelus.";
RL   Submitted (NOV-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Cooperates with LY96 and CD14 to mediate the innate immune
CC       response to bacterial lipopolysaccharide (LPS). Acts via MYD88, TIRAP
CC       and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the
CC       inflammatory response (By similarity). Also involved in LPS-independent
CC       inflammatory responses triggered by free fatty acids, such as
CC       palmitate. In complex with TLR6, promotes sterile inflammation in
CC       monocytes/macrophages in response to oxidized low-density lipoprotein
CC       (oxLDL) or amyloid-beta 42. In this context, the initial signal is
CC       provided by oxLDL- or amyloid-beta 42-binding to CD36. This event
CC       induces the formation of a heterodimer of TLR4 and TLR6, which is
CC       rapidly internalized and triggers inflammatory response, leading to the
CC       NF-kappa-B-dependent production of CXCL1, CXCL2 and CCL9 cytokines, via
CC       MYD88 signaling pathway, and CCL5 cytokine, via TICAM1 signaling
CC       pathway, as well as IL1B secretion. Binds electronegative LDL (LDL(-))
CC       and mediates the cytokine release induced by LDL(-) (By similarity).
CC       Activated by the signaling pathway regulator NMI which acts as damage-
CC       associated molecular patterns (DAMPs) in response to cell injury or
CC       pathogen invasion, therefore promoting nuclear factor NF-kappa-B
CC       activation (By similarity). {ECO:0000250|UniProtKB:O00206,
CC       ECO:0000250|UniProtKB:Q9QUK6}.
CC   -!- SUBUNIT: Belongs to the lipopolysaccharide (LPS) receptor, a multi-
CC       protein complex containing at least CD14, LY96 and TLR4. Binding to
CC       bacterial LPS leads to homodimerization. Interacts with LY96 via the
CC       extracellular domain. Interacts with MYD88 and TIRAP via their
CC       respective TIR domains. Interacts with TICAM2. Interacts with NOX4.
CC       Interacts with CNPY3 and HSP90B1; this interaction is required for
CC       proper folding in the endoplasmic reticulum. Interacts with MAP3K21;
CC       this interaction leads to negative regulation of TLR4 signaling.
CC       Interacts with CD36, following CD36 stimulation by oxLDL or amyloid-
CC       beta 42, and forms a heterodimer with TLR6. The trimeric complex is
CC       internalized and triggers inflammatory response. LYN kinase activity
CC       facilitates TLR4-TLR6 heterodimerization and signal initiation.
CC       Interacts with TICAM1 in response to LPS in a WDFY1-dependent manner.
CC       Interacts with WDFY1 in response to LPS. Interacts with SMPDL3B.
CC       Interacts with CEACAM1; upon lipopolysaccharide stimulation, forms a
CC       complex including TLR4 and the phosphorylated form of SYK and CEACAM1,
CC       which in turn, recruits PTPN6 that dephosphorylates SYK, reducing the
CC       production of reactive oxygen species (ROS) and lysosome disruption,
CC       which in turn, reduces the activity of the inflammasome. Interacts with
CC       RFTN1; the interaction occurs in response to lipopolysaccharide
CC       stimulation. Interacts with SCIMP; the interaction occurs in response
CC       to lipopolysaccharide stimulation and is enhanced by phosphorylation of
CC       SCIMP by LYN (By similarity). This interaction facilitates the
CC       phosphorylation of TLR4 by LYN which elicits a selective cytokine
CC       response in macrophages (By similarity). Interacts with TRAF3IP3 (By
CC       similarity). Interacts with TREM1; this interaction enhances TLR4-
CC       mediated inflammatory response (By similarity).
CC       {ECO:0000250|UniProtKB:O00206, ECO:0000250|UniProtKB:Q9QUK6}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:O00206};
CC       Single-pass type I membrane protein {ECO:0000250|UniProtKB:O00206}.
CC       Early endosome {ECO:0000250|UniProtKB:O00206}. Cell projection, ruffle
CC       {ECO:0000250|UniProtKB:Q9QUK6}. Note=Upon complex formation with CD36
CC       and TLR6, internalized through dynamin-dependent endocytosis.
CC       Colocalizes with RFTN1 at cell membrane and then together with RFTN1
CC       moves to endosomes, upon lipopolysaccharide stimulation.
CC       {ECO:0000250|UniProtKB:O00206}.
CC   -!- DOMAIN: The TIR domain mediates interaction with NOX4.
CC       {ECO:0000250|UniProtKB:O00206}.
CC   -!- PTM: Phosphorylated on tyrosine residues by LYN after binding
CC       lipopolysaccharide. {ECO:0000250|UniProtKB:Q9QUK6}.
CC   -!- SIMILARITY: Belongs to the Toll-like receptor family. {ECO:0000305}.
CC   -!- CAUTION: In some plant proteins and in human SARM1, the TIR domain has
CC       NAD(+) hydrolase (NADase) activity (By similarity). However, despite
CC       the presence of the catalytic Asp residue, the isolated TIR domain of
CC       human TLR4 lacks NADase activity (By similarity). Based on this, it is
CC       unlikely that Toll-like receptors have NADase activity.
CC       {ECO:0000250|UniProtKB:O00206, ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ286730; ABB97024.1; -; mRNA.
DR   AlphaFoldDB; Q2V898; -.
DR   SMR; Q2V898; -.
DR   GO; GO:0005769; C:early endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0046696; C:lipopolysaccharide receptor complex; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0001726; C:ruffle; IEA:UniProtKB-SubCell.
DR   GO; GO:0001875; F:lipopolysaccharide immune receptor activity; ISS:UniProtKB.
DR   GO; GO:0050135; F:NAD(P)+ nucleosidase activity; IEA:UniProtKB-EC.
DR   GO; GO:0061809; F:NAD+ nucleotidase, cyclic ADP-ribose generating; IEA:UniProtKB-EC.
DR   GO; GO:0004888; F:transmembrane signaling receptor activity; IEA:InterPro.
DR   GO; GO:0032497; P:detection of lipopolysaccharide; ISS:UniProtKB.
DR   GO; GO:0006954; P:inflammatory response; IEA:UniProtKB-KW.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0032731; P:positive regulation of interleukin-1 beta production; ISS:UniProtKB.
DR   GO; GO:1900227; P:positive regulation of NLRP3 inflammasome complex assembly; ISS:UniProtKB.
DR   GO; GO:0002224; P:toll-like receptor signaling pathway; IEA:InterPro.
DR   Gene3D; 3.40.50.10140; -; 1.
DR   Gene3D; 3.80.10.10; -; 1.
DR   InterPro; IPR000483; Cys-rich_flank_reg_C.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR003591; Leu-rich_rpt_typical-subtyp.
DR   InterPro; IPR026906; LRR_5.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   InterPro; IPR000157; TIR_dom.
DR   InterPro; IPR017241; Toll-like_receptor.
DR   InterPro; IPR035897; Toll_tir_struct_dom_sf.
DR   PANTHER; PTHR24365; PTHR24365; 1.
DR   Pfam; PF13306; LRR_5; 1.
DR   Pfam; PF13855; LRR_8; 3.
DR   Pfam; PF01582; TIR; 1.
DR   PIRSF; PIRSF037595; Toll-like_receptor; 1.
DR   SMART; SM00369; LRR_TYP; 13.
DR   SMART; SM00082; LRRCT; 1.
DR   SMART; SM00255; TIR; 1.
DR   SUPFAM; SSF52200; SSF52200; 1.
DR   PROSITE; PS51450; LRR; 13.
DR   PROSITE; PS50104; TIR; 1.
PE   2: Evidence at transcript level;
KW   Cell membrane; Cell projection; Disulfide bond; Endosome; Glycoprotein;
KW   Immunity; Inflammatory response; Innate immunity; Leucine-rich repeat;
KW   Membrane; NAD; Receptor; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000255"
FT   CHAIN           24..841
FT                   /note="Toll-like receptor 4"
FT                   /id="PRO_0000253497"
FT   TOPO_DOM        24..632
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        633..653
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        654..841
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REPEAT          55..76
FT                   /note="LRR 1"
FT   REPEAT          79..100
FT                   /note="LRR 2"
FT   REPEAT          103..124
FT                   /note="LRR 3"
FT   REPEAT          127..148
FT                   /note="LRR 4"
FT   REPEAT          151..172
FT                   /note="LRR 5"
FT   REPEAT          176..197
FT                   /note="LRR 6"
FT   REPEAT          205..225
FT                   /note="LRR 7"
FT   REPEAT          352..373
FT                   /note="LRR 8"
FT   REPEAT          374..395
FT                   /note="LRR 9"
FT   REPEAT          400..422
FT                   /note="LRR 10"
FT   REPEAT          423..444
FT                   /note="LRR 11"
FT   REPEAT          448..469
FT                   /note="LRR 12"
FT   REPEAT          472..495
FT                   /note="LRR 13"
FT   REPEAT          497..518
FT                   /note="LRR 14"
FT   REPEAT          521..542
FT                   /note="LRR 15"
FT   REPEAT          545..568
FT                   /note="LRR 16"
FT   DOMAIN          579..630
FT                   /note="LRRCT"
FT   DOMAIN          673..816
FT                   /note="TIR"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00204"
FT   REGION          820..841
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        826..841
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CARBOHYD        35
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        73
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        205
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        238
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        282
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        309
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        497
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        526
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        570
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        575
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        625
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        29..40
FT                   /evidence="ECO:0000250|UniProtKB:O00206"
FT   DISULFID        281..306
FT                   /evidence="ECO:0000250|UniProtKB:O00206"
FT   DISULFID        390..391
FT                   /evidence="ECO:0000250|UniProtKB:O00206"
FT   DISULFID        583..609
FT                   /evidence="ECO:0000250|UniProtKB:O00206"
FT   DISULFID        585..628
FT                   /evidence="ECO:0000250|UniProtKB:O00206"
SQ   SEQUENCE   841 AA;  96108 MW;  04AE24C2D523119E CRC64;
     MMARVRLAAA LIPATAILSC LRTESWDPCV QVVPNISYQC MELNLYKIPD NIPISTKMLD
     LSFNYLRHLG SHNFSSFPEL QVLDLSRCEI KIIEDDTFQG LNHLSTLILT GNPIQSLAWG
     AFSGLSSLQK LVAVETNLVS LNDFPIGHLK TLKELNVAHN FIHSFKLPEY FSNLPNLEHL
     DLSNNKIQNI YYEDVKVLHQ MPLLNLSLDL SLNPLDFIEP GTFKEIKLNG LTLRSNFNSS
     HVMKTCIQGL AGLKINRLVL GEFKNERKLK GFDRSILEGL CNLTIEQFRI AYLDEFSGDD
     TDLFNCLENV SVISLLSVSL GSLQALLKDF RWQHLEIINC DFDKFPALKL SSLKKFVFTD
     NKDISSFTEF QLPSLQYLDL RRNHLSFKGC CSHADFGTTN LKHLDLSFND VITLGSNFMG
     LEKLEHLDFQ HSTLKQINAF SVFLSLRNLR YLDISYTNVR IVFHGIFTGL VSLKTLKMAG
     NTFQDNLLPD IFTELTNLTV LDLSKCQLEQ VAQTAFHSLS SLQVLNMSHN KLLSLDTFLY
     EPLHLLRILD CSFNRIMDSK EQDLQNLPRN LTWLNLTQNA FACVCEHQRF LQWVKDQRQL
     LVGAEQMMCA EPLDMKDMPV LSFRNATCQM SKMIISVSVV TVLLVSVVGV LVYKFYFHLM
     LLAGCKKYGR GESTYGAFVI YSSQDEDWVR NELVKNLEEG VPPFQLCLHY RDFIPGVAIA
     ANIIQEGFHK SRKVIVVVSQ HFIQSRWCIF EYEIAQTWQF LSSRAGIIFI VLQKLEKSLL
     RQQVELYRLL SRNTYLEWED SVLGRHVFWR RLRKALLAGK PQSPEGTADA ETNPQEATTS
     T
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024